I really don't think there is anything positive or negative to read into this statement that we didn't already know.
It's taken along time to accrue the MACE events (a positive) but we already knew this.
The trial is still yet to be un-blinded so until then, nothing can be assumed.
If anything I'm a little disappointed that the results are still so far away - but that is just my impatience, no reflection on the results.
So we continue to wait.
Ann: CHF P3 Trial Accrues Sufficient Primary Endpoint Events, page-18
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.49 |
Change
0.140(10.4%) |
Mkt cap ! $1.701B | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.54 | $1.37 | $23.10M | 15.82M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 24758 | $1.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 73626 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |